K-numberK253752
Device nameARTIS genio floor; ARTIS icono.explore floor
ApplicantSiemens Medical Solutions USA, Inc.
Product codeOWB
Device classClass II
Decision dateApr 23, 2026
DecisionSubstantially Equivalent
Regulation892.1650
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ARTIS genio floor and ARTIS icono.explore floor are dedicated angiography systems designed for single-plane and biplane diagnostic imaging and interventional procedures. They enable visualization of blood vessels and allow physicians to navigate catheters and devices safely during cardiac, neuro, and general angiography procedures, as well as surgical guidance and image-guided interventions.

Technological characteristics

The subject devices feature updated system software (VE50B versus VE40A), including enhanced peristepping/perivision for leg visualization, new postprocessing algorithms (Advanced I-Noise and Extended Overlay Reference), updated touch UI, revised collimators, updated hardware, an optional new Trixell 2121S flat detector, and modifications to tables and floor stands. All components maintain the same functional architecture as the predicate with improved imaging and user interface capabilities.

Test standards cited

Testing verified compliance with IEC 60601 series standards for medical electrical equipment safety, IEC 62304 for software lifecycle processes, ISO 13485 for quality management, ISO 14971 for risk management, IEC 60825-1 for laser safety, and NEMA DICOM standards for medical imaging communications. Bench testing, software validation, and clinical image evaluation were all conducted with passing results.

Substantial equivalence argument

The subject devices are substantially equivalent because they perform the same intended functions as the predicate ARTIS icono (VE40A) for angiographic imaging and interventional procedures. The modifications represent evolutionary improvements in software, hardware, and user interface that do not change the fundamental device design or safety profile; non-clinical performance testing demonstrates the devices are as safe and effective as the predicate for the same indicated uses.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →